Tuberculosis remains one of the world’s deadliest infectious diseases, killing 1. 23 million people in 2024, according to the ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five ...

Tuberculosis (TB) is the world's biggest infectious disease killer, with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study led by the Swiss Tropical and Public ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

The Experimental Tuberculosis Unit (UTE) at the Germans Trias i Pujol Research Institute (IGTP) has published in Nature ...

Researchers at UMass Amherst have combined high-throughput laboratory screening with an AI neural network to identify ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

The exposure may have occurred between Dec. 15, 2025, and May 14, 2026 at CSUSM's main campus on 333 S. Twin Oaks Valley Road in San Marcos.

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...